SA Hurvitz
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer-related Molecular Pathways
-
- Advanced Breast Cancer Therapies
Papers in
- Oncology 38
- HER2/EGFR in Cancer Research 22
- Cancer Treatment and Pharmacology 21
- Cancer Diagnosis and Treatment 3
-
- Advanced Breast Cancer Therapies 21
- Co-authors
- Fabrice André (6 shared papers)Mario Campone (5 shared papers)Tarek Sahmoud (3 shared papers)Ilona Pylvaenaeinen (2 shared papers)DJ Slamon (8 shared papers)H. S. Rugo (4 shared papers)John A. Glaspy (2 shared papers)José Baselga (3 shared papers)
- Journals
- Cancer Research (23 papers)Journal of Clinical Oncology (9 papers)Annals of Oncology (4 papers)European Journal of Cancer (2 papers)Journal of Thoracic and Cardiovascular Surgery (1 paper)
- Partner nations
- United StatesSwitzerlandSpain
In The Last Decade
SA Hurvitz
43 papers receiving 310 citations
Peers
Comparison fields: 5 of 33
- Oncology 211
- Pulmonary and Respiratory Medicine 130
- Cancer Research 50
- Genetics 25
- Radiology, Nuclear Medicine and Imaging 51
Countries citing papers authored by SA Hurvitz
This map shows the geographic impact of SA Hurvitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SA Hurvitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SA Hurvitz more than expected).
Fields of papers citing papers by SA Hurvitz
This network shows the impact of papers produced by SA Hurvitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SA Hurvitz. The network helps show where SA Hurvitz may publish in the future.
Co-authors
The 25 scholars most cited alongside SA Hurvitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 43 | |
| 2 | 2011 | 28 | |
| 3 | 2010 | 26 | |
| 4 | 2018 | 21 | |
| 5 | 2018 | 20 | |
| 6 | 2022 | 20 | |
| 7 | 2010 | 20 | |
| 8 | 2009 | 15 | |
| 9 | 2009 | 13 | |
| 10 | 2011 | 13 | |
| 11 | 2018 | 10 | |
| 12 | 2017 | 9 | |
| 13 | 2010 | 7 | |
| 14 | 2008 | 7 | |
| 15 | 2019 | 5 | |
| 16 | 2019 | 5 | |
| 17 | 2012 | 4 | |
| 18 | 2010 | 4 | |
| 19 | 1989 | 4 | |
| 20 | 1963 | 4 |
About SA Hurvitz
SA Hurvitz is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 45 papers that have together received 320 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (22 papers), Cancer Treatment and Pharmacology (21 papers), Advanced Breast Cancer Therapies (21 papers), Breast Cancer Treatment Studies (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Cancer Diagnosis and Treatment (3 papers), Kruppel-like factors research (3 papers) and Fibroblast Growth Factor Research (3 papers). The work is most often cited by research in Oncology (211 citations), Pulmonary and Respiratory Medicine (130 citations), Cancer Research (50 citations), Genetics (25 citations) and Radiology, Nuclear Medicine and Imaging (51 citations). SA Hurvitz has collaborated with scholars based in United States, Switzerland and Spain. Frequent co-authors include Fabrice André, Mario Campone, Tarek Sahmoud, Ilona Pylvaenaeinen, DJ Slamon, H. S. Rugo, John A. Glaspy, José Baselga, Steven Applebaum and RS Finn. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer and Journal of Thoracic and Cardiovascular Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.